Treatment with carvedilol was associated with a nonsignificant risk reduction for mortality compared with metoprolol for diabetic and nondiabetic patients, the researchers note. 卡維地洛與美托洛爾相比，沒(méi)有明顯降低糖尿病和非糖尿病患者的死亡風(fēng)險。
Diabetic patients with neuropathy or vasculopathy have higher complication rates than both diabetic patients without these comorbidities and nondiabetic patients. 有神經(jīng)病變或血管病變的糖尿病患者與無(wú)這些合并疾病的糖尿病患者和非糖尿病患者相比，并發(fā)癥的發(fā)生率更高。
